89 related articles for article (PubMed ID: 1477648)
1. F-MACHOP in advanced aggressive lymphoma.
Guglielmi C; Amadori S; Martelli M; Papa G; Mandelli F
Leuk Lymphoma; 1992 Jun; 7(3):205-9. PubMed ID: 1477648
[TBL] [Abstract][Full Text] [Related]
2. The F-MACHOP regimen in advanced diffuse aggressive lymphomas: summary of ten years' experience at a single institution.
Guglielmi C; Amadori S; Martelli M; Papa G; Mandelli F
Leukemia; 1991; 5 Suppl 1():102-4. PubMed ID: 1890858
[No Abstract] [Full Text] [Related]
3. MACOP-B vs F-MACHOP regimen in the treatment of high-grade non-Hodgkin's lymphomas.
Mazza P; Zinzani PL; Martelli M; Fiacchini M; Bocchia M; Pileri S; Falini B; Martelli MF; Amadori S; Papa G
Leuk Lymphoma; 1995 Feb; 16(5-6):457-63. PubMed ID: 7540460
[TBL] [Abstract][Full Text] [Related]
4. How do patients with aggressive non-Hodgkin's lymphoma treated with third-generation regimens (MACOP-B and F-MACHOP) fare in the long-term?
Zinzani PL; Martelli M; Magagnoli M; Zaja F; Storti S; Pavone E; Lauta VM; De Renzo A; Gobbi M; Bocchia M; Ronconi F; Scaramucci L; Gherlinzoni F; Palombi F; Bendandi M; Stefoni V; Anticoli Borza P; Cellini C; Mandelli F; Tura S
Haematologica; 1999 Nov; 84(11):996-1001. PubMed ID: 10553159
[TBL] [Abstract][Full Text] [Related]
5. The F-MACHOP sequential combination chemotherapy regimen in advanced diffuse aggressive lymphomas: long-term results.
Guglielmi C; Amadori S; Martelli M; Dragoni F; Mandelli F
Ann Oncol; 1991 May; 2(5):365-71. PubMed ID: 1954181
[TBL] [Abstract][Full Text] [Related]
6. Clinical and pathological restaging in aggressive non-Hodgkin's lymphomas.
Mandelli F; Amadori S; Guglielmi C; Martelli M; Coluzzi S
Leukemia; 1991; 5 Suppl 1():38-41. PubMed ID: 1890864
[TBL] [Abstract][Full Text] [Related]
7. MACOP-B vs F-MACHOP in the treatment of high-grade non-Hodgkin's lymphomas.
Tura S; Mandelli F; Mazza P; Pileri S; Gherlinzoni F; Bocchia M; Zinzani PL; Fiacchini M; Martelli M; Papa G
Leukemia; 1991; 5 Suppl 1():74-8. PubMed ID: 1716338
[TBL] [Abstract][Full Text] [Related]
8. Mediastinal large-B-cell lymphoma with sclerosis: a clinical study of 21 patients.
Todeschini G; Ambrosetti A; Meneghini V; Pizzolo G; Menestrina F; Chilosi M; Benedetti F; Veneri D; Cetto GL; Perona G
J Clin Oncol; 1990 May; 8(5):804-8. PubMed ID: 1692089
[TBL] [Abstract][Full Text] [Related]
9. Sequential combination chemotherapy of high-grade non-Hodgkin's lymphoma with 5-fluorouracil, methotrexate, cytosine-arabinoside, cyclophosphamide, doxorubicin, vincristine, and prednisone (F-MACHOP).
Guglielmi C; Amadori S; Anselmo AP; Baroni CD; Biagini C; Cimino G; Papa G; Mandelli F
Cancer Invest; 1987; 5(3):159-69. PubMed ID: 3651863
[TBL] [Abstract][Full Text] [Related]
10. High-dose chemotherapy followed by autologous bone marrow transplantation versus dexamethasone, cisplatin, and cytarabine in aggressive non-Hodgkin's lymphoma with partial response to front-line chemotherapy: a prospective randomized italian multicenter study.
Martelli M; Vignetti M; Zinzani PL; Gherlinzoni F; Meloni G; Fiacchini M; De Sanctis V; Papa G; Martelli MF; Calabresi F; Tura S; Mandelli F
J Clin Oncol; 1996 Feb; 14(2):534-42. PubMed ID: 8636768
[TBL] [Abstract][Full Text] [Related]
11. Treatment of diffuse aggressive non-Hodgkin's lymphomas with an intensive multi-drug regimen including high-dose cytosine arabinoside (F-MACHOP).
Amadori S; Guglielmi C; Anselmo AP; Cimino G; Ruco LP; Papa G; Biagini C; Mandelli F
Semin Oncol; 1985 Jun; 12(2 Suppl 3):218-22. PubMed ID: 4012340
[No Abstract] [Full Text] [Related]
12. Combination chemotherapy for the treatment of diffuse aggressive lymphomas: F-MACHOP update.
Guglielmi C; Amadori S; Ruco LP; Mantovani L; Martelli M; Papa G; Mandelli F
Semin Oncol; 1987 Jun; 14(2 Suppl 1):104-9. PubMed ID: 3589684
[No Abstract] [Full Text] [Related]
13. The F-MACHOP regimen in the treatment of aggressive non-Hodgkin's lymphomas: a single center experience in 72 patients.
Infanti L; Silvestri F; Fanin R; Salmaso F; Zaja F; Barillari G; Patriarca F; Geromin A; Cerno M; Damiani D; Baccarani M
Haematologica; 1996; 81(6):521-8. PubMed ID: 9009439
[TBL] [Abstract][Full Text] [Related]
14. Primary mediastinal large B-cell lymphoma (PMLBCL): long-term results from a retrospective multicentre Italian experience in 138 patients treated with CHOP or MACOP-B/VACOP-B.
Todeschini G; Secchi S; Morra E; Vitolo U; Orlandi E; Pasini F; Gallo E; Ambrosetti A; Tecchio C; Tarella C; Gabbas A; Gallamini A; Gargantini L; Pizzuti M; Fioritoni G; Gottin L; Rossi G; Lazzarino M; Menestrina F; Paulli M; Palestro M; Cabras MG; Di Vito F; Pizzolo G
Br J Cancer; 2004 Jan; 90(2):372-6. PubMed ID: 14735179
[TBL] [Abstract][Full Text] [Related]
15. Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma.
Fisher RI; Gaynor ER; Dahlberg S; Oken MM; Grogan TM; Mize EM; Glick JH; Coltman CA; Miller TP
N Engl J Med; 1993 Apr; 328(14):1002-6. PubMed ID: 7680764
[TBL] [Abstract][Full Text] [Related]
16. MACOP-B versus ProMACE-MOPP in the treatment of advanced diffuse non-Hodgkin's lymphoma: results of a prospective randomized trial by the non-Hodgkin's Lymphoma Cooperative Study Group.
Sertoli MR; Santini G; Chisesi T; Congiu AM; Rubagotti A; Contu A; Salvagno L; Coser P; Porcellini A; Vespignani M
J Clin Oncol; 1994 Jul; 12(7):1366-74. PubMed ID: 7517442
[TBL] [Abstract][Full Text] [Related]
17. Late relapse in patients with diffuse large-cell lymphoma treated with MACOP-B.
Lee AY; Connors JM; Klimo P; O'Reilly SE; Gascoyne RD
J Clin Oncol; 1997 May; 15(5):1745-53. PubMed ID: 9164181
[TBL] [Abstract][Full Text] [Related]
18. Anaplastic large-cell lymphoma: clinical and prognostic evaluation of 90 adult patients.
Zinzani PL; Bendandi M; Martelli M; Falini B; Sabattini E; Amadori S; Gherlinzoni F; Martelli MF; Mandelli F; Tura S; Pileri SA
J Clin Oncol; 1996 Mar; 14(3):955-62. PubMed ID: 8622045
[TBL] [Abstract][Full Text] [Related]
19. Effects of Mega-COMLA (cyclophosphamide, cytarabine, vincristine, and methotrexate followed by leucovorin and prednisone) plus CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone) in the treatment of lymphoid neoplasms with very poor prognosis.
Hainsworth JD; Wolff SN; Stein RS; Greer JP; Cousar JB; Greco FA
Cancer Treat Rep; 1986 Aug; 70(8):953-8. PubMed ID: 3015406
[TBL] [Abstract][Full Text] [Related]
20. Southwest Oncology Group clinical trials for intermediate- and high-grade non-Hodgkin's lymphomas.
Miller TP; Dana BW; Weick JK; Jones SE; Coltman CA; Dahlberg S; Fisher RI
Semin Hematol; 1988 Apr; 25(2 Suppl 2):17-22. PubMed ID: 2456619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
